Belite Bio, Inc
BLTE
$63.22
$1.191.92%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
7/10/2025
-
MarketBeat
7/10/2025
-
MarketBeat
7/9/2025
-
Market News Video
7/9/2025
-
MarketBeat
7/7/2025
-
MarketBeat
7/3/2025
-
MarketBeat
7/3/2025
-
GuruFocus
7/2/2025
-
Simply Wall St
7/2/2025
-
The Fly
7/2/2025
-
GuruFocus
7/2/2025
-
GuruFocus
7/2/2025
-
Globe Newswire
6/30/2025
-
MarketBeat
6/17/2025
-
MarketBeat
6/17/2025
-
MarketBeat
6/11/2025
-
MarketBeat
6/9/2025
-
MarketBeat
6/9/2025
-
MarketBeat
6/8/2025
-
Ticker Report
6/7/2025
-
MarketBeat
6/6/2025
-
Market News Video
6/6/2025
-
MarketBeat
6/5/2025
-
The Fly
6/4/2025
-
The Fly
6/3/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, March 17, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 246 6240
Address
12750 High Bluff Drive
San Diego, CA 92130
San Diego, CA 92130
Country
Year Founded
Business Description
Sector
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet...
more